Phase
Condition
Nephropathy
Hyperparathyroidism
Parathyroid Disorders
Treatment
18F-PET
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Patients with reduced renal function:
Inclusion Criteria:
-≥ 18 years
estimated Glomerular Filtration Rate (eGFR) ≤ 20 ml/min/1,73m2
PTH < 150 pg/ml or PTH > 300 pg/ml
Exclusion
Exclusion Criteria:
ongoing malignancy
Allergy towards tetracyclin
Pregnancy
Control Group:
Inclusion Criteria:
-≥ 18 years
eGFR >= 60 ml/min
under examination for c prostata
Prostatic Specific Antigen (PSA) total <40 µg/l
Exclusion:
Former kidney disease
ionized calcium or PTH outside normal range
Known metabolic bone disease
treatment with anticoagulants
Disturbed thrombosis and hemostasis
Study Design
Study Description
Connect with a study center
Herlev Hospital
Herlev, 2730
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.